$SMMT Cashflow Statement | Understand Stock

$SMMT

$15.33 +$0.83 (5.72%) Close

$SMMT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows used in operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Gain on recognition of contingent consideration payable
Gain on remeasurement of liabilities
Non-cash interest expense
Amortization of discount on short-term investments
Unrealized foreign exchange loss (gain)
Impairment of fixed assets
Amortization of operating right-of-use assets
Depreciation
Amortization of intangible assets
Impairment of intangible assets
Stock-based compensation
Other adjustments
Loss on disposal of assets
Acquired in-process research and development expense
Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses
Prepaid expenses and other current assets
Other assets
Research and development tax credit receivable
Deferred revenue and other income
Accounts payable
Accrued liabilities and accrued compensation
Accrued liabilities and other current liabilities
Accrued compensation
Other long-term liabilities
Operating lease right-of-use assets and lease liabilities, net

Net cash used in operating activities
Cash flows used in investing activities:
Maturities and sales of short-term investments
Purchase of short-term investments
Purchase of property and equipment
Proceeds from sale of property, plant and equipment
Payments to Akeso for upfront milestone payments and associated direct transaction costs
Net cash used in investing activities
Cash flows provided by financing activities:
Proceeds from the issuance of common stock via private placements, net of offering costs
Proceeds from exercise of warrants
Proceeds received related to employee stock purchase plan and exercise of stock options
Proceeds from related party promissory notes
Payments of related party promissory notes issuance costs
Proceeds from exercise of share options
Net cash provided by financing activities

Effect of exchange rates on cash
Effect of exchange rates on cash and cash equivalents
Increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Supplemental Disclosure of Cash Flow Information:
Cash paid for income taxes
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Debt issuance costs in accrued expenses
Transaction costs included in accrued expenses
Leased assets obtained in exchange for operating lease liabilities
Unpaid amounts related to purchase of property, plant and equipment
Issuance of common stock
Rights Offering
Akeso License Agreement
Deferred transaction costs included in other non-current assets

Comments